Fundraising FoxBrightlands Venture Partners
Venture capitalGeleen · Seed–Series B · 14 people tracked
Find your way into Brightlands Venture Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Christoph Lynen to introduce you to Pierpaolo Padula
You →Christoph · together at Psylaris →Pierpaolo
Ask Jamie Chen to introduce you to Marcel Lubben
You →Jamie · together at yet2.com →Marcel
Ask Sam Okafor to introduce you to Carmel van den Berk
You →Sam · together at Nitinotes Surgical →Carmel
- Luc Starmans183 people can intro you
- Marcel Kloosterman170 people can intro you
- Casper Bruens152 people can intro you
Sign up to find every way you can get introduced to Brightlands Venture Partners
- Your email: who you already know at Brightlands Venture Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Brightlands Venture Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
BVP backs outlier founders building scalable companies that strengthen essential societal systems. The firm concentrates on the health, agrifood, and renewable chemistry sectors, aiming to support ventures that improve foundational systems society relies on. Drawing on roughly two decades of investing experience since 2004, the firm has raised four funds and invested more than €120M across these essential-systems themes, backing over 50 companies. Its activity spans six geographies across the EU and the US.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & curated & public directories
What they invest in
from 18 of 50 portfolio companiesBiotech ×8New Materials ×8Healthtech ×6Medical Devices ×5AgTech ×4Circular Economy ×4Deep Tech ×3Digital Health ×3
HQs:Netherlands×11Germany×3Japan×1United States×1
Investments · 50 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 22022 · 22021 · 22019 · 22017 · 22011 · 12010 · 113 dated
S&dB develops seed germination solutions using proprietary production methods for professional growers globally.
AgTechClimate TechNew Materials
Gerard Otten(Founder, CTO/COO)Harmen Smid(Founder, CEO)
AVL Motion builds a second-generation asparagus harvesting robot, the AVL Compact S9000, for agricultural growers.
AgTechHardwareRobotics
Co-investorsBOMFFFFuture Food Fund
Circularise provides supply chain traceability software that helps companies trace materials across complex value chains, connect data to products, and share verifiable information.
Circular EconomyLogistics & Supply ChainNew MaterialsSaaSDelft, NL
Mesbah Sabur(Co-Founder)inJordi de Vos(Co-Founder)in
Co-investors4impact capitalAsahi Kasei Corporate Venture Capital
Corporis Medical develops medical devices for surgical and diagnostic applications, focusing on innovations like perfusion measurement systems and clinical validation.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMaastricht, NL
Alexander Veenhof(Surgeon, MD, Founder)in
Co-investorsInkefUnorthodox Ventures
Cristal Therapeutics develops therapeutics in the life sciences sector.
BiotechDeep TechDigital HealthMedical DevicesUtrecht, NL
Dr. Cristianne Rijcken(Chief Scientific Officer and Founder)Dr. Joost Holthuis(Co-founder and former CEO)
Co-investorsBioGeneration VenturesChemelot VenturesThuja CapitalBOMDroia Ventures
Grassa extracts functional ingredients from grass through a decentralized pressing and refining process integrated into dairy farming operations.
AgTechCircular EconomyFoodTechWageningen, NL
Kipster operates a poultry farm producing eggs and meat with a focus on animal welfare and low environmental impact, feeding its chickens with residual products from the food industry such as large bakeries to reduce waste and land use.
AgTechFoodTechImpact & Social Good
Ruud Zanders(Co-founder)
Kriya Materials develops nanoparticle-based coating systems and dispersions for optical applications, covering functions such as anti-reflection, anti-static, anti-fouling and hardcoats.
Advanced ManufacturingDeep TechNew MaterialsNuth, NL
Co-investorsSHIFT InvestChemelot VenturesHolland Capital
Develops and produces contrast agents and devices for in-vivo MRI imaging of implants, transplants and minimally invasive devices such as catheters and guidewires.
Co-investorsBioScience Ventures Group AG
Niostem develops a drug-free, wearable device based on stem cell research to treat hair loss and promote hair regrowth.
ConsumerHardwareHealthtechBerlin, DE
Carlos Chacon(Founding CEO & Current CTO)inSamuel Jellard(Cofounder)in
Co-investorsEntrepreneur First
Oxford Performance Materials develops additive manufacturing (3D printing) technology and high-performance PEKK thermoplastics and coatings.
Advanced ManufacturingMedical DevicesNew MaterialsSouth Windsor, US
Scott DeFelice(Executive Officer, Director)inJordan DeFelice(Executive Officer, Director)inPaul Martin(Executive Officer, Director)inSeverine Zygmont(Executive Officer, Director)Anthony DeCarmine(Executive Officer)Christopher Codeanne(Executive Officer)in
PL BioScience develops human platelet-based cell culture media that promote cell growth, used in biotechnology research and cell culture applications.
BiotechNew Materials
Dr. Hatim Hemeda(Founder & CEO)
Co-investorsAvant BioTechVision FondsBetter Ventures Central Llc
.png)
Psylaris develops virtual reality tools for mental health practitioners to support exposure therapy, EMDR, and stress reduction as part of clinical treatment in Dutch mental health care settings.
Digital HealthHealthtechMental HealthMaastricht, NL
Christoph Lynen(Founder/CTO)in
Co-investorsY Combinator
Qorium develops cell-cultured leather grown from a single animal cell sample, producing uniform collagen sheets that integrate into existing tannery and leather-goods production processes.
BiotechCircular EconomyNew Materials
Co-investorsSofinnova PartnersInvest-NL
ReSolved Technologies develops solvent-based recycling technology to recover high-quality engineering plastics and PVC from complex waste streams for closed-loop manufacturing.
Circular EconomyCleantechNew MaterialsGeleen, NL
Silicozyme develops customizable enzymatic toolkits for biologics refinement and general processing applications.
BiotechNew Materials
Co-investorsChemelot Ventures
Takeda is a global pharmaceutical company that develops medicines and treatments for patients, focused on advancing science, technology, and partnerships to create new standards of care.
BiotechHealthtechTokyo, JP
Claudia D'Augusta(Executive Officer)inEduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)inWilfried Dalemans(Executive Officer)
BoardJune Almenoff(Director)Russell Greig(Director)
Co-investorsKleiner PerkinsRho VenturesYsios CapitalKreos Capital
Vivalyx develops organ revitalization technology aimed at improving organ vitality for transplantation.
BiotechHealthtechMedical DevicesAachen, DE
Benedict Doorschodt(Founder)in
Co-investorsGOOSE CapitalNextGen VenturesSeed Fonds AachenTechVision FondsTechVision FundBessemer Venture Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ACS BiomarkerAliformBasic PharmaBioActorBlack Bear CarbonChemtrixCuroTisEkompany AgroEnzyPepEnzyTagFABPulousFortimedixFortimedix SurgicalFuenixGreencoveryHealth Value CreationIoniqa TechnologiesIsobionicsMatisse PharmaceuticalsNeuroplastNovenda TechnologiesPectcofPharmaCellQ ChipQC PolymersReSolved TechnologiesS+dBSoilwiseTripleMedVerdifyVertoro
Portfolio news
latest coverage across their companiesQorium · finsmes.com · Nov 11, 2025
Frequently asked questions
- How many investments has Brightlands Venture Partners made?
- Brightlands Venture Partners has 50 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Brightlands Venture Partners invest at?
- Brightlands Venture Partners invests at the Seed, Series A, Series B stages.
- What is Brightlands Venture Partners's typical check size?
- Brightlands Venture Partners typically writes checks of $540K – $2.2M.
- What sectors does Brightlands Venture Partners focus on?
- Brightlands Venture Partners focuses on AgTech, Biotech, Cleantech, FoodTech, Healthtech, Medical Devices, New Materials.
- Where is Brightlands Venture Partners located?
- Brightlands Venture Partners is headquartered in Geleen, NL.
- Does Brightlands Venture Partners lead rounds?
- Brightlands Venture Partners typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamMarcel Kloosterman and Jeffrey Williams about Brightlands Venture Partners
Brightlands Chemelot Campus · Marcel Kloosterman
Images
Co-investors · 1
Alchemy Partners is a UK-based private equity and special situations investment firm managing capital across private equity and special opportunities (distressed debt and special situations) strategies.
Firms observed investing alongside Brightlands Venture Partners, from public investor directories. Shared companies are the overlap with Brightlands Venture Partners's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.